Athens Medical Csa Stock Beta
| IATR Stock | EUR 1.54 0.01 0.65% |
Athens Medical CSA fundamentals help investors to digest information that contributes to Athens Medical's financial success or failures. It also enables traders to predict the movement of Athens Stock. The fundamental analysis module provides a way to measure Athens Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Athens Medical stock.
Athens |
Athens Medical CSA Company Beta Analysis
Athens Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Athens Medical Beta | 1.02 |
Most of Athens Medical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Athens Medical CSA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Athens Medical CSA has a Beta of 1.0222. This is 18.86% higher than that of the Healthcare sector and 18.22% lower than that of the Health Care Plans industry. The beta for all Greece stocks is notably lower than that of the firm.
Athens Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Athens Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Athens Medical could also be used in its relative valuation, which is a method of valuing Athens Medical by comparing valuation metrics of similar companies.Athens Medical is currently under evaluation in beta category among its peers.
Athens Medical returns are very sensitive to returns on the market. As the market goes up or down, Athens Medical is expected to follow.
Athens Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0317 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 354.02 M | |||
| Shares Outstanding | 86.74 M | |||
| Shares Owned By Insiders | 80.82 % | |||
| Price To Earning | 18.79 X | |||
| Price To Book | 0.59 X | |||
| Price To Sales | 0.54 X | |||
| Revenue | 226 M | |||
| Gross Profit | 57.79 M | |||
| EBITDA | 34.78 M | |||
| Net Income | 15.05 M | |||
| Cash And Equivalents | 4.59 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 129.39 M | |||
| Debt To Equity | 184.80 % | |||
| Current Ratio | 0.90 X | |||
| Book Value Per Share | 1.17 X | |||
| Cash Flow From Operations | 15.75 M | |||
| Earnings Per Share | 0.12 X | |||
| Number Of Employees | 2.8 K | |||
| Beta | 1.02 | |||
| Market Capitalization | 145.28 M | |||
| Total Asset | 422.76 M | |||
| Retained Earnings | 12 M | |||
| Working Capital | (147 M) | |||
| Current Asset | 124 M | |||
| Current Liabilities | 271 M | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.50 % | |||
| Net Asset | 422.76 M | |||
| Last Dividend Paid | 0.07 |
About Athens Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Athens Medical CSA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Athens Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Athens Medical CSA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Athens Stock Analysis
When running Athens Medical's price analysis, check to measure Athens Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athens Medical is operating at the current time. Most of Athens Medical's value examination focuses on studying past and present price action to predict the probability of Athens Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athens Medical's price. Additionally, you may evaluate how the addition of Athens Medical to your portfolios can decrease your overall portfolio volatility.